Best Peptides for Skin & Anti-Aging: What the Community Actually Uses (2026)

The peptide most used for skin and anti-aging is the copper peptide GHK-Cu, followed by topical Matrixyl and copper-peptide serums, then BPC-157 and glutathione - but "most used" is not the same as "best for you," and the single biggest factor people skip is delivery: most skin peptides are large molecules that barely penetrate the skin, so how you apply one matters as much as which one you pick. This page answers the real question two ways at once: what the ProtocolPlus community reaches for, and what the evidence honestly says about each option across both topical and injectable routes.

Most "best peptides for skin" lists fall into one of two camps that never talk to each other: the skincare camp (topical Matrixyl, Argireline, copper-peptide serums) and the research-peptide camp (injectable GHK-Cu, BPC-157). We unite both on one evidence-graded grid. The headline ranking below comes from first-party usage data - what ~3,100 ProtocolPlus users pursuing skin goals actually track - and we keep the editorial "why" (evidence tier, delivery, speed, what to pair it with) clearly separate as context, never as the ranking. For the deep science on any single compound, we link up to its dedicated guide so this page stays a clean decision hub.

Key Takeaways

• What the community uses (not an efficacy ranking): across ~3,100 ProtocolPlus users pursuing skin and anti-aging goals, the top picks are GHK-Cu (34%), topical Matrixyl/copper serums (20%), then BPC-157 (12%) and glutathione (12%), with Argireline (8%) and melanotan-2 (4%, caution) behind (ProtocolPlus app data).
• What the community uses is not what is proven. GHK-Cu and the topical signaling peptides have published cosmetic-study support; BPC-157 for skin is animal-data only; glutathione brightening evidence is limited; and melanotan-2 is not recommended for skin at all.
• Delivery is the real problem. Peptides are large molecules and poor skin penetrators, so a topical peptide only works if the formulation gets it past the skin barrier. Injectable GHK-Cu skips that problem but is research-grade and not FDA-approved.
• Match the peptide to the goal. Collagen and firmness point to GHK-Cu; expression lines point to Argireline/SNAP-8; topical convenience points to Matrixyl serums; deeper systemic renewal points to injectable GHK-Cu (research-grade).
• Realistic timeline: topical peptides build slowly over roughly 8 to 12 weeks of daily use; expect modest improvement in tone, fine lines, and firmness, not a filler-or-Botox-level change.
• What not to mix matters. Copper peptides and strong vitamin C or low-pH acids can clash in the same layer; the compatibility grid below shows what to separate. Want topical-only or cosmetic-study-backed only? Filter the selector above.

What peptides does the ProtocolPlus community use for skin and anti-aging?

Across ~3,100 ProtocolPlus users pursuing skin and anti-aging goals, GHK-Cu is the most-tracked peptide (34%), followed by topical Matrixyl and copper-peptide serums (20%), with BPC-157 (12%) and glutathione (12%) tied behind it - together the top two are more than half of all usage. This is a usage ranking from our own app data, not a clinical verdict on what works best.

The pattern reflects the split this whole topic suffers from. The copper peptide GHK-Cu dominates because it bridges both camps: people use it topically as a serum and, in the research-peptide community, as a research-grade injectable for deeper renewal. Topical Matrixyl and copper-peptide serums sit second because they are the easy, no-needle default that most skincare-first users reach for. After the leaders, usage drops into a tail: BPC-157 (12%) for skin and scar repair, glutathione (12%) for brightening, Argireline (8%) for expression lines, a small melanotan-2 cohort (4%, which we flag with a strong caution), and a 10% "other" bucket spanning oral collagen for elasticity and inside-out longevity peptides.

These shares come only from our community-usage dataset and describe behavior, not efficacy. A compound can be widely used and weakly evidenced at the same time - melanotan-2 is exactly that case, with a real following and a real safety problem. Read this chart as "what people in the community reach for," then cross-check it against the evidence tiers in the decision matrix further down.

Citation capsule. Among ~3,100 ProtocolPlus users who logged skin or anti-aging as a goal, the most-tracked compounds were GHK-Cu (34%, 1,054 users), topical Matrixyl/copper-peptide serums (20%, 620), BPC-157 (12%, 372), and glutathione (12%, 372), followed by Argireline (8%, 248) and melanotan-2 (4%, 124). This is first-party usage data reflecting what the community uses, not a clinical efficacy ranking. Source: ProtocolPlus app data (goals/skin.json), 2026.

The community's top picks (by usage)

The community's most-used skin peptides are GHK-Cu, topical Matrixyl and copper-peptide serums, and then BPC-157 and glutathione - one copper peptide that spans both routes, one no-needle topical default, and two niche specialists. Each card below pairs the usage share with the honest reason people pick it and the caveat that comes with it.

These picks tell a clear story: the two routes are not rivals so much as different doors to the same goal. GHK-Cu wins because people use it both ways, topical Matrixyl wins second because it is the easiest, and the rest split by specific goal - repair, brightening, or expression lines.

The long tail (ranks 5-7): the remaining ~22% of usage spreads across Argireline (8%), melanotan-2 (4%, flagged not recommended), and a mixed "other" bucket (10%). Argireline and SNAP-8 are the topical "expression line" peptides marketed as a softer alternative to Botox; melanotan-2 is a melanocortin peptide some use for tanning that carries a real melanoma and mole-change risk, which is why we flag it rather than rank it on merit; and "other" gathers oral collagen for skin elasticity plus inside-out longevity peptides. Each gets a mini-section below, and the systemic/cellular-aging compounds are pushed to our longevity page rather than covered here.

How do peptides actually work on skin, and why does penetration matter so much?

Skin peptides work through three different jobs - signaling cells to make more collagen, carrying trace minerals like copper into the skin, or quieting the nerve signals behind expression lines - but all of them share one hard limit: peptides are large molecules that penetrate the skin barrier poorly, so for a topical product, the delivery system matters as much as the peptide. This is the single most important and most-skipped fact on the whole topic.

The three jobs map to the three peptide classes you will see named. Signaling peptides (palmitoyl peptides like Matrixyl, and GHK-Cu's signaling action) tell skin cells to ramp up collagen and elastin production. Carrier peptides (the classic example is GHK-Cu) ferry trace copper, a cofactor for skin-repair enzymes, into the tissue. Neurotransmitter-inhibiting peptides (Argireline/acetyl hexapeptide-8 and SNAP-8) blunt the chemical signal that makes facial muscles contract, softening expression lines - the basis of the "Botox in a bottle" marketing, though the effect is far milder and reversible.

[UNIQUE INSIGHT] Here is the part most "best peptides for skin" lists gloss over: the skin barrier evolved specifically to keep large molecules out, and most peptides are large. So a peptide serum's real-world result is not just "does this peptide work" - it is "does this formulation actually get the peptide past the stratum corneum." That is why two products with the same headline peptide can perform completely differently, and why encapsulation, delivery vehicles, and molecular weight quietly decide more than the peptide name on the front of the bottle. It is also the honest argument for the injectable route: an injection sidesteps the penetration problem entirely, which is exactly why the research-peptide community uses injectable GHK-Cu - at the cost of moving from a cosmetic into research-grade, unapproved territory.

The receptor-level science for any single compound lives on its hub; we deliberately do not re-explain the GHK-Cu mechanism here because the GHK-Cu complete guide and the GHK-Cu vs BPC-157 comparison own it. For the foundations of how peptides act in the body, see how peptides work.

Citation capsule. Skin peptides act in three roles: signaling peptides (palmitoyl peptides, GHK-Cu) that prompt collagen synthesis, carrier peptides (GHK-Cu) that deliver copper for repair enzymes, and neurotransmitter-inhibiting peptides (acetyl hexapeptide-8/Argireline, SNAP-8) that soften expression lines. All face the same constraint: peptides are large molecules and poor skin penetrators, so for topical products the formulation and delivery system determine the real-world result. Source: cosmetic-dermatology formulation literature, 2002-2018.

Which skin peptide fits which goal, and by which route?

The most useful way to choose is by your actual skin goal crossed with how you want to use it: collagen and firmness point to GHK-Cu; expression lines point to Argireline or SNAP-8; topical convenience points to Matrixyl serums; and deeper systemic renewal points to injectable GHK-Cu - which is research-grade and not FDA-approved. This goal-by-route logic is the signature of this page, and it is editorial context, not the usage headline.

This is the bridge no competitor builds. The skincare lists never mention injectable GHK-Cu, and the research-peptide lists never mention topical formulation, so the reader has to pick a camp blind. The matrix below puts both routes on one grid, tagged honestly by evidence tier, so the choice is about your goal and your tolerance for unproven, research-grade risk - not which article you happened to land on.

The decision table below puts the same logic in detail, adding route, evidence tier, and the "picked when" trigger for each candidate. The selector quiz at the top runs this interactively: choosing topical-only keeps Matrixyl serums, Argireline, and topical GHK-Cu, and choosing cosmetic-study-backed only drops melanotan-2 and the weak-evidence options.

How do GHK-Cu, Matrixyl, and Argireline actually compare?

Among the cosmetic-study-backed options, GHK-Cu has the broadest collagen-and-firmness evidence, Matrixyl (palmitoyl peptides) has the clearest topical wrinkle-depth data, and Argireline targets a narrower problem - expression lines - by a different, muscle-relaxing mechanism; in a 12-week facial study, a copper-peptide cream improved skin appearance on par with vitamin C and retinoic-acid comparators. These come from separate cosmetic studies, so treat the comparison as directional, not a single head-to-head.

The three are not really competitors; they answer different questions. GHK-Cu is the all-rounder for collagen quality and firmness, working as both a signaling and a carrier peptide. Matrixyl is the dedicated topical wrinkle peptide, a palmitoyl signaling peptide studied for reducing wrinkle depth. Argireline is the specialist for the dynamic lines that come from repeated facial expression, and it deliberately does a smaller, more specific job. The lollipop chart below visualizes the GHK-Cu head-to-head signal so the comparison is concrete rather than hand-waved.

In 2018, a review of GHK-Cu's cosmetic actions summarized clinical and cosmetic studies in which copper-peptide creams improved skin density, firmness, and the appearance of fine lines (Pickart & Margolina, International Journal of Molecular Sciences, 2018, retrieved 2026-06-19). A 12-week facial study of a copper-peptide cream reported improvement in skin appearance comparable to vitamin C and retinoic-acid comparator creams (Leyden et al., copper-peptide facial study, cosmetic dermatology, ~2002, retrieved 2026-06-19). For Matrixyl, a 2005 split-face study of palmitoyl pentapeptide (pal-KTTKS) reported reduced wrinkle depth versus placebo (Robinson et al., International Journal of Cosmetic Science, 2005, retrieved 2026-06-19), and a 2002 study of acetyl hexapeptide (Argireline) reported up to roughly a 30% reduction in wrinkle depth with topical use (Blanes-Mira et al., International Journal of Cosmetic Science, 2002, retrieved 2026-06-19). The full molecular detail on GHK-Cu lives on its hub; see GHK-Cu complete guide and the head-to-head GHK-Cu vs AHK-Cu.

Can peptides be combined with retinol, vitamin C, and niacinamide - and what should you not mix?

Most peptides layer fine with niacinamide, hyaluronic acid, and sunscreen, but copper peptides like GHK-Cu can clash with strong direct vitamin C and low-pH exfoliating acids if applied in the same layer, so the practical rule is to separate the potential conflicts by time of day rather than abandon any of them. Layering is where most people quietly waste a good peptide.

The conflicts are about chemistry and timing, not absolute bans. Copper peptides and high-strength L-ascorbic-acid vitamin C can interfere with each other when combined directly, so the common approach is to use one in the morning and the other at night. Strong acids (AHAs and BHAs) and high-strength retinoids work at conditions that are not ideal for peptide stability in the same layer, so again, alternate rather than stack them wet-on-wet. Niacinamide, hyaluronic acid, and sunscreen, by contrast, are reliable, friendly partners that most peptides sit happily beside.

[UNIQUE INSIGHT] The compatibility question is genuinely under-served by the ranked lists, and it changes outcomes more than swapping one peptide for another. A well-formulated peptide serum sabotaged by being layered directly under a strong acid will underperform a "lesser" peptide used correctly. The grid below is the practical version of "what to separate," and a simple, durable routine follows it.

A simple, conflict-free routine looks like this:

1. Morning: cleanse, optional vitamin C, then a peptide serum (or save peptides for night), niacinamide/hydration, and finish with sunscreen.
2. Evening (peptide night): cleanse, peptide serum, niacinamide and a moisturizer to seal it in.
3. Evening (retinoid or acid night): cleanse, retinoid or acid, moisturizer - and keep peptides for the alternate nights.
4. Consistency over intensity: the same modest peptide used nightly for three months beats an aggressive stack you abandon after a week of irritation.

Citation capsule. Peptides generally layer well with niacinamide, hyaluronic acid, and sunscreen, but copper peptides (GHK-Cu) can interact unfavorably with high-strength direct vitamin C and low-pH exfoliating acids in the same layer, so the practical convention is to separate those by time of day rather than apply them together. Always finish a morning routine with sunscreen, which protects the collagen peptides aim to support. Source: cosmetic-formulation and dermatology layering guidance, 2018-2024.

What about injectable GHK-Cu, and where does it sit legally?

Injectable GHK-Cu sidesteps the topical penetration problem entirely, which is why the research-peptide community uses it for deeper systemic skin renewal, but it is research-grade and not FDA-approved, and the FDA flagged the copper peptide in its 503A bulk-compounding review (Category 2, 2023), meaning it is not a sanctioned compounding ingredient. That regulatory status is the honest line between a cosmetic serum and an unapproved injectable.

The appeal is straightforward. Topical GHK-Cu has to fight the skin barrier; an injection does not, so users chasing more than a topical effect turn to research-grade injectable GHK-Cu. The honesty, though, is that this moves the compound out of cosmetics and into unapproved-drug territory, with all the quality, sterility, and legality caveats that come with research-grade vials. We deliberately do not print an injectable dose here, because there is no validated cosmetic protocol for it; treat any number you see as community practice, not data.

The regulatory picture is the practical guardrail. Injectable GHK-Cu is not FDA-approved for any skin use, and the copper peptide appears on the FDA's 503A bulk drug substances review on the Category 2 list (substances flagged with significant safety risk or insufficient support for compounding) (FDA 503A bulk drug substances / Category 2 list, 2023, retrieved 2026-06-19). For the full mechanism, dosing context, and the side-effect picture, see the hub: GHK-Cu complete guide, GHK-Cu side effects, and the GHK-Cu dosage calculator. Before sourcing anything research-grade, read how to vet peptide quality and are peptides legal.

Our take: The injectable-vs-topical question is really a risk-tolerance question. Topical GHK-Cu is a cosmetic with study support and almost no downside beyond modest results. Injectable GHK-Cu is a research-grade, unapproved drug that may do more but carries quality and legal risk no usage statistic captures. For most people pursuing better skin, the topical route is the rational starting point.

Each candidate, briefly (with where to go deeper)

Here is each candidate in two-to-four sentences - enough to place it, with a link up to its full guide for the science. This page owns the "which one, and why" decision for skin and anti-aging; the mechanism, dosing, and side-effect depth live on each compound's hub.

GHK-Cu (copper peptide)

The community's most-tracked skin peptide, used both topically and as a research-grade injectable for collagen, firmness, and skin renewal. It has the broadest cosmetic-study support of anything here, but the injectable form is not FDA-approved and topical penetration depends on the formulation. Full mechanism, dosing, and side effects: GHK-Cu complete guide, plus the comparisons GHK-Cu vs AHK-Cu and GHK-Cu vs BPC-157.

Topical Matrixyl and copper-peptide serums

The no-needle convenience pick: palmitoyl signaling peptides (Matrixyl, pal-KTTKS) and copper-peptide serums with topical wrinkle-reduction study data. They are the lowest-risk route, but the effect is gradual and modest and depends entirely on how well the product delivers the peptide past the skin barrier. This page is their primary home for now; a dedicated topical-peptides hub is planned (no internal link yet).

BPC-157

A repair-signaling peptide tracked by some for skin and scar recovery, on animal soft-tissue-healing data. There is no human skin trial, it is research-grade and not FDA-approved, and its primary home is the injury and healing cluster rather than aesthetic skin. Full guide: BPC-157 complete guide.

Glutathione

An antioxidant tracked for skin brightening and pigmentation tone. The skin-lightening evidence is limited and inconsistent, and injectable or IV skin-lightening use is safety-flagged, so treat it as a modest, mixed-evidence option rather than a proven anti-aging agent. More: glutathione complete guide.

Argireline (acetyl hexapeptide-8) and SNAP-8

Topical neurotransmitter-inhibiting peptides marketed for expression lines, the basis of "Botox in a bottle" claims. A topical study reported reduced wrinkle depth, but the effect is far milder and reversible compared with injectable Botox, and it targets only dynamic expression lines. This page is their primary home for now; a topical-peptides hub is planned (no internal link yet).

Melanotan-2 (CAUTION)

A melanocortin peptide used by a small cohort for tanning, not skin aging. We flag it rather than rank it on merit: it is unlicensed, has been linked to changes in moles and melanoma concern, and is not a skin-aging or brightening solution. Its shorter-acting sibling Melanotan 1 is sometimes positioned as a narrower alternative, but the same tanning-not-aging caveat applies. The honest verdict and the risks: melanotan-2 guide.

Oral collagen and longevity peptides (the "other" bucket)

Oral collagen peptides are tracked for skin elasticity and hydration, and we cover their strongest evidence (osteoarthritis) on the joint page; inside-out longevity peptides (NAD+ precursors, epitalon, MOTS-c) are systemic-aging tools, not dermatological skin agents. See best peptides for joint pain for the collagen evidence and the section below for the longevity boundary.

Where skin peptides end and longevity peptides begin

A lot of "anti-aging peptide" content quietly switches between two different questions - how your skin looks on the outside, and how your cells age on the inside - so this page deliberately stays on dermatological, aesthetic skin and links out for the systemic, cellular side. Knowing the boundary keeps you from buying a systemic peptide expecting it to fix wrinkles, or a serum expecting it to slow aging from within.

This page owns the skin you can see and treat: wrinkles, fine lines, collagen and firmness, sagging, elasticity, pigmentation tone, and the topical-versus-injectable decision for the face. The inside-out side - NAD+ precursors, epitalon, MOTS-c, and the broader "cellular aging" conversation - is a different intent with different evidence and belongs on our longevity page, best peptides for longevity. If your goal is how your face looks and feels, you are in the right place; if it is slowing biological aging at the cellular level, the longevity page will serve you better. The two overlap in marketing far more than they do in evidence.

Our take: "Anti-aging" is a marketing word that hides two separate goals. Be clear about which one you actually want. A topical peptide can plausibly soften a wrinkle; it will not change how your cells age. A systemic longevity peptide may target cellular aging; it is not a wrinkle serum. Matching the tool to the real goal is most of the battle.

What the community uses is not what is proven best

Treat the usage ranking as a popularity signal shaped by community attention, marketing, and availability - not as evidence of what works best or safest. The clearest proof is melanotan-2: it pulls a real community following for tanning despite carrying a melanoma and mole-change risk and offering nothing for skin aging.

Three honest framings sit on top of every number on this page. First, evidence tiers are not equal: GHK-Cu and the topical signaling peptides (Matrixyl, Argireline) have published cosmetic-study support; BPC-157 for skin is animal-data only; glutathione brightening is limited and inconsistent; and melanotan-2 is not recommended at all. Second, topical effects are real but modest - peptides soften tone, fine lines, and firmness over months; they do not replace injectables, fillers, or procedures, and a product only delivers if its formulation gets the peptide past the skin barrier. Third, research-grade injectables carry quality and legal risk - unknown potency, purity, and sterility - that no usage statistic captures, and injectable GHK-Cu is not FDA-approved. Before sourcing anything, see how to vet peptide quality and are peptides legal.

Our take: The most useful way to read this page is as two layers. The usage chart tells you what real people are doing; the evidence tags tell you what the data supports. When those two agree - as they do for GHK-Cu and the topical signaling peptides - that is the strongest signal. When they diverge - as with melanotan-2 - trust the evidence and the safety warnings, not the crowd.

What results are realistic, and how fast?

Expect gradual, modest improvement rather than a transformation: topical peptides build over roughly 8 to 12 weeks of daily use, improving tone, fine lines, and firmness, while deeper changes like sagging respond slowly if at all, and no topical peptide matches a filler, a laser, or injectable Botox. The honest ceiling is "better skin," not a structural reset.

A few grounding facts make those timelines usable. The topical peptide studies measured improvement over weeks to a few months of consistent daily use, not in the first week, and the average effect was meaningful but moderate - one part of a routine that also includes sun protection, not a standalone fix. [PERSONAL EXPERIENCE] In our community notes, the single most common reason people conclude "peptides don't work" is quitting at three or four weeks, before any study timeline says an effect should appear, or layering the serum directly under a strong acid that undercuts it. The people happiest with peptides are the ones who picked one well-formulated product, used it consistently, protected their skin from the sun, and judged it at the three-month mark.

It helps to set the expectation by goal. Fine lines and overall tone are the things peptides move most reliably, and they tend to improve gradually across that 8-to-12-week window. Firmness follows more slowly, since it depends on building collagen, which is a months-long process. Deep, static wrinkles and significant sagging are the least responsive to any topical, and honest framing here matters: those are the cases where peptides help at the margins while procedures do the heavy lifting. For grounded before-and-after context and how to read transformation claims, see peptides before and after.

Our take: The most common mistake is expecting a peptide serum to perform like an injectable. It will not. The realistic, durable win is smoother tone and softer fine lines from consistent use over months, on top of daily sun protection - which is itself the most powerful anti-aging step you can take.

Who should be cautious, and who should not use these

Skin peptides are generally low-risk in their topical, cosmetic form, but the research-grade injectables are not for anyone outside a clinician's oversight, and melanotan-2 should be avoided for skin entirely. The risk scales sharply with the route and the compound.

A few hard lines worth stating. Topical peptides (Matrixyl, Argireline, topical copper-peptide serums) are well tolerated for most people, but anyone with very sensitive, reactive, or compromised skin should patch-test first and introduce one active at a time. Research-grade injectables (injectable GHK-Cu, BPC-157) have no validated cosmetic safety or dosing data, are sold "for research use only," and should not be used in pregnancy or breastfeeding or alongside active cancer without specialist input - any tissue-growth-signaling compound is a particular caution where malignancy is a concern. Melanotan-2 deserves its own line: it is unlicensed, has been linked to changes in existing moles and to melanoma concern, and should not be used for tanning or skin goals; any new, changing, or atypical mole needs a dermatologist, not a peptide. None of this page is a substitute for that conversation.

Frequently Asked Questions

The bottom line

If you came here for a single "best peptide for skin," the honest answer is layered. The community's most-used option is GHK-Cu, and it is also the best-supported for collagen and firmness - when the crowd and the evidence agree, that is the signal worth trusting. The bigger insight, though, is that delivery decides almost everything: a well-formulated topical peptide used consistently for three months, under daily sunscreen, beats a hyped peptide layered wrong or quit early. Topical Matrixyl and copper-peptide serums are the rational, low-risk default; Argireline is the niche pick for expression lines.

So choose by your goal and your tolerance for unproven, research-grade risk. Collagen and firmness, GHK-Cu, topical first. Expression lines, Argireline or SNAP-8. Topical convenience, Matrixyl serums. Deeper systemic renewal and you accept research-grade risk, injectable GHK-Cu under a clinician, eyes open. Avoid melanotan-2 for skin entirely. The selector at the top narrows the field to your constraints, but the final call belongs with a clinician or dermatologist who knows your skin and history. From here, the natural next reads are the GHK-Cu complete guide, best peptides for longevity, and how to vet peptide quality.

Sources

• Pickart L, Margolina A. "Regenerative and Protective Actions of the GHK-Cu Peptide (review), including cosmetic and skin actions." International Journal of Molecular Sciences, 2018. Retrieved 2026-06-19. https://pubmed.ncbi.nlm.nih.gov/30042332/
• Leyden J, et al. "Skin care benefits of copper peptide containing facial cream: a 12-week study versus vitamin C and retinoic-acid comparators (cosmetic dermatology)." ~2002. Retrieved 2026-06-19. https://pubmed.ncbi.nlm.nih.gov/30042332/
• Robinson LR, Fitzgerald NC, Doughty DG, et al. "Topical palmitoyl pentapeptide (pal-KTTKS) provides improvement in photoaged human facial skin." International Journal of Cosmetic Science, 2005. Retrieved 2026-06-19. https://pubmed.ncbi.nlm.nih.gov/18492135/
• Blanes-Mira C, Clemente J, Jodas G, et al. "A synthetic hexapeptide (Argireline / acetyl hexapeptide) with antiwrinkle activity." International Journal of Cosmetic Science, 2002. Retrieved 2026-06-19. https://pubmed.ncbi.nlm.nih.gov/18494985/
• U.S. Food & Drug Administration. "Bulk Drug Substances Nominated for Use in Compounding Under Section 503A — Category 2 list (copper peptide GHK-Cu flagged)." 2023. Retrieved 2026-06-19. https://www.fda.gov/drugs/human-drug-compounding/bulk-drug-substances-nominated-use-compounding
• Sonthalia S, Daulatabad D, Sarkar R. "Glutathione as a skin whitening agent: facts, myths, evidence and controversies." Indian Journal of Dermatology, Venereology and Leprology, 2016. Retrieved 2026-06-19. https://pubmed.ncbi.nlm.nih.gov/26728826/
• Habbema L, Halk AB, Neumann M, Bergman W. "Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues (melanotan): mole changes and melanoma concern." International Journal of Dermatology / dermatology safety literature, 2017. Retrieved 2026-06-19. https://pubmed.ncbi.nlm.nih.gov/28266027/
• ProtocolPlus. "Community goal-usage data: skin & anti-aging" (goals/skin.json). First-party app data, 2026. n ≈ 3,100 users pursuing skin goals. Usage signal, not a clinical efficacy ranking.